Stay updated on MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial
Sign up to get notified when there's something new on the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page.

Latest updates to the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page
- Check3 days agoChange DetectedThe MT-6402 Phase 1 study record is displayed with its clinical details and record history; the study is listed as terminated by the sponsor and no longer recruiting.SummaryDifference71%

- Check10 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the study page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedA banner about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the existing 403 error page.SummaryDifference1%

- Check24 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check31 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to show a 403 error.SummaryDifference0.2%

- Check52 days agoChange DetectedRevision: v3.7.0 was added and a large set of historical metadata and MeSH terms was removed from the study record, signaling a simplification of the page's metadata/history section.SummaryDifference21%

Stay in the know with updates to MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page.